Takaya Togo

Computer ScienceBiochemistry, Genetics and Molecular BiologyMedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Expanding automated multiconformer ligand modeling to macrocycles and fragments”.

Expanding automated multiconformer ligand modeling to macrocycles and fragments

eLife(2025)10.7554/elife.103797

N/A

0.360DataRank · unranked

10 citations

Nathaniel Echols, G.J. Correy, Priya Jaishankar, Takaya Togo, Adam R. Renslo +4 more

Expanding automated multiconformer ligand modeling to macrocycles and fragments

eLife(2025)10.7554/elife.103797.3

N/A

0.165DataRank · unranked

2 citations

Nathaniel Echols, G.J. Correy, Priyadarshini Jaishankar, Takaya Togo, Adam R. Renslo +4 more

Expanding Automated Multiconformer Ligand Modeling to Macrocycles and Fragments

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.20.613996

N/A

0.104DataRank · unranked

1 citations

Nathaniel Echols, G.J. Correy, Priya Jaishankar, Takaya Togo, Adam R. Renslo +4 more

The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2

eLife(2025)10.7554/elife.103484.3

N/A

0.104DataRank · unranked

1 citations

Priyadarshini Jaishankar, G.J. Correy, Moira Rachman, Patrick C. O’Leary, Taha Y. Taha +26 more

Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.11.681833

N/A

0DataRank · unranked

3 citations

G.J. Correy, Yusuke Matsui, Takaya Togo, Moira Rachman, Maisie GV Stevens +14 more

Reviewer #2 (Public review): The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2

(2025)10.7554/elife.103484.1.sa1

N/A

0DataRank · unranked

0 citations

Priyadarshini Jaishankar, Galen J Correy, Moira M Rachman, Patrick C O’Leary, Taha Y Taha +22 more

Expanding Automated Multiconformer Ligand Modeling to Macrocycles and Fragments

eLife(2025)10.7554/elife.103797.2

N/A

0DataRank · unranked

0 citations

Nathaniel Echols, G.J. Correy, Priya Jaishankar, Takaya Togo, Adam R. Renslo +4 more

The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2

eLife(2025)10.7554/elife.103484

N/A

0DataRank · unranked

7 citations

Priyadarshini Jaishankar, G.J. Correy, Moira Rachman, Patrick C. O’Leary, Taha Y. Taha +26 more

Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.25.609621

N/A

0DataRank · unranked

9 citations

Moira Rachman, Takaya Togo, Stefan Gahbauer, Yagmur U. Doruk, Maisie GV Stevens +12 more

A Comprehensive Empirical–Computational Study of Diverse Het-eroarene Stacking under Physiological Conditions

ChemRxiv(2022)10.26434/chemrxiv-2022-359ch

N/A

0DataRank · unranked

0 citations

Takaya Togo, Linh Tram, Laura Denton, Xochina ElHilali-Pollard, Jun Gu +13 more

Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.25.696505

N/A

0DataRank · unranked

5 citations

G.J. Correy, Brendan W. Hall, Moira Rachman, Olivier Mailhot, Takaya Togo +15 more